Trial Agreement

This Trial Agreement (“Agreement”) governs your non-commercial evaluation access to Simit software and Services (the “Trial”). By requesting or using the Trial, you agree to this Agreement.

1. Scope and Eligibility

The Trial is provided solely for evaluation and testing. You must be of legal age and authorized by your organization (if applicable) to accept this Agreement.

2. Evaluation License and Restrictions (No Production Use)

Subject to this Agreement, Simit grants you a limited, non-exclusive, non-transferable, revocable license to use the Trial solely for internal evaluation. You will not:

• Use the Trial in production or for any revenue-generating or commercial purpose.
• Reverse engineer, decompile, or attempt to derive source code, except as permitted by law.
• Circumvent technical limits or usage controls.
• Publish benchmarks without prior written consent.

3. Confidentiality and NDA Obligations

You may receive non-public information from Simit and may share feedback or evaluation data. Each party will protect the other’s Confidential Information with reasonable care and use it only for evaluation. If a separate NDA is in place, it controls in case of conflict.

4. Trial Data Handling and Privacy

Personal data, if processed during the Trial, will be handled as described in our Privacy Policy. Do not provide production or sensitive personal data unless agreed in writing.

5. Feedback License

You grant Simit a non-exclusive, perpetual, irrevocable, royalty-free license to use feedback and suggestions you provide for any purpose.

6. No Fees; Support and Availability

The Trial is provided at no charge and without service-level commitments. We may provide reasonable support on a best-effort basis.

7. Warranty Disclaimer and Liability Limits

THE TRIAL IS PROVIDED “AS IS” WITHOUT WARRANTIES OF ANY KIND. TO THE MAXIMUM EXTENT PERMITTED BY LAW, SIMIT WILL NOT BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, OR ANY LOSS OF PROFITS, REVENUE, DATA, OR GOODWILL. SIMIT’S TOTAL LIABILITY UNDER THIS AGREEMENT WILL NOT EXCEED USD $100.

8. Term and Termination

Unless otherwise agreed, the Trial begins when access is granted and ends on the earlier of the communicated end date or our notice of termination. Upon termination, you must stop using the Trial and delete any Trial components and confidential information in your possession.

9. Export and Compliance

You must comply with applicable export control and sanctions laws. You represent that you are not restricted under applicable trade laws.

10. Entire Agreement; Order of Precedence

This Agreement is the entire agreement for the Trial. If you have a separate written agreement with Simit that expressly governs evaluations, that agreement will control to the extent of any conflict.